Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

January 17, 2022

MSR1 and NEP Are Correlated with Alzheimer's Disease Amyloid Pathology and Apolipoprotein Alterations.

Journal of Alzheimer's Disease : JAD
Justin MironPREVENT-AD research group
January 16, 2022

Impact of intestinal disorders on central and peripheral nervous system diseases.

Neurobiology of Disease
Yumna El-HakimFarida Sohrabji
January 16, 2022

Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing.

Molecular Metabolism
Christian HuismanDaniel L Marks
January 15, 2022
Review

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?

Molecular Neurobiology
Theoharis C Theoharides
January 15, 2022

Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours.

Journal of Extracellular Vesicles
Xiaoyu YuHonghong Yao
January 14, 2022
Preprint
Open Access

Helicobacter Pylori Urease: Potential Contributions to Alzheimer’s Disease

Preprints.org
Augusto F. UbertiCelia Regina Carlini
January 14, 2022

Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Charles E SeaksDonna M Wilcock
January 13, 2022
Review

Myeloperoxidase: a new target for the treatment of stroke?

Neural Regeneration Research
Yun-Chang WangYi-Nian Zhang
January 13, 2022

microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury.

Neural Regeneration Research
Jian-Song ZhangQin Hu
January 13, 2022

Gut microbes shape microglia and cognitive function during malnutrition.

Glia
Kylynda C BauerBarton Brett Finlay
January 12, 2022
Review
Open Access

Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies.

International Journal of Molecular Sciences
Anamaria Jurcau, Aurel Simion
January 12, 2022

Screening the Efficacy of Melatonin on Neurodegeneration Mediated by Endoplasmic Reticulum Stress, Inflammation, and Oxidative Damage.

Applied Biochemistry and Biotechnology
Fathima Hajee Basha, S Hemalatha

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/blood-brain-barrier-cytokines/177d3517-977b-435c-852d-c7d365bb7903